THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

WOLVERINE ASSET MANAGEMENT LLC's Holding History (CIK: 0001279891)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 1,500,000 Value ($000) $1,414 Avg Close — Range —
Q1 2021
Shares 20,600,000 Value ($000) $20,968 Avg Close — Range —
Q4 2020
Shares 24,100,000 Value ($000) $22,817 Avg Close — Range —
Q3 2020
Shares 24,100,000 Value ($000) $21,294 Avg Close — Range —
Q2 2020
Shares 24,100,000 Value ($000) $23,476 Avg Close — Range —
Q1 2020
Shares 24,100,000 Value ($000) $23,717 Avg Close — Range —
Q4 2019
Shares 24,100,000 Value ($000) $24,989 Avg Close — Range —
Q3 2019
Shares 24,100,000 Value ($000) $22,397 Avg Close — Range —
Q2 2019
Shares 24,100,000 Value ($000) $20,926 Avg Close — Range —
Q1 2019
Shares 24,100,000 Value ($000) $23,451 Avg Close — Range —
Q4 2018
Shares 24,100,000 Value ($000) $24,760 Avg Close — Range —
Q3 2018
Shares 24,100,000 Value ($000) $28,543 Avg Close — Range —
Q2 2018
Shares 24,100,000 Value ($000) $23,789 Avg Close — Range —
Q1 2018
Shares 24,100,000 Value ($000) $24,481 Avg Close — Range —
Q4 2017
Shares 24,100,000 Value ($000) $26,424 Avg Close — Range —
Q3 2017
Shares 24,020,000 Value ($000) $29,431 Avg Close — Range —
Q2 2017
Shares 24,020,000 Value ($000) $32,436 Avg Close — Range —
Q1 2017
Shares 21,000,000 Value ($000) $26,657 Avg Close — Range —
Q4 2016
Shares 21,000,000 Value ($000) $24,181 Avg Close — Range —